*New Format*As a prospective investor we invite you to join InSitu Biologic’s CEO Jim Segermark for a conference call to answer your questions. Jim will be available […]
*New Format*As a prospective investor we invite you to join InSitu Biologic’s CEO Jim Segermark for a conference call to answer your questions. Jim will be available […]
As a prospective investor we invite you to join us for a live Q&A webcast where we will discuss our Matrix BioHydrogel, and our pre-clinical stage, long-lasting […]
As a prospective investor we invite you to join us for a live Q&A webcast where we will discuss our Matrix BioHydrogel, and our pre-clinical stage, long-lasting […]
As a prospective investor we invite you to join us for a live Q&A webcast where we will discuss our Matrix BioHydrogel, and our pre-clinical stage, long-lasting […]
Join us for a veterinarian webcast with Stacie Lipinski, DVM, and Jim Segermark, CEO of InSitu Biologics on Tuesday, June 11th 8:30PM EST / 5:30PM PST. They will discuss […]
Join InSitu Biologics CEO Jim Segermark, CSO Bill Taylor and Medical Advisor Jake Hutchins MD to learn about its long-lasting and long-acting non-opiate painkiller, AnestaGel. Update: These […]
InSitu Biologics Corporate from InSitu Biologics
We’re hosting a get together to network and have Dr. Jake Hutchins MD, Executive Medical Director at M Health Ambulatory Surgery Center, discuss the advancements made within […]
I hope this letter finds you off to a great 2019. To receive timely information on your Company, please check back here or head on over to […]
Casual conversation, drinks, appetizers & NCAA Sweet 16 Hoops Thursday, March 28th | 5-?? PM D’Arcy’s Tavern – Bradley Beach, NJ* *Reservation Required RSVP: https://www.eventbrite.com/e/investing-in-biotech-investors-for-non-opiate-pain-solutions-dinner-tickets-58183002928